President and Chief Scientific OfficerDr. Kurt Stoeckli
Dr. Kurt Stoeckli is President and Chief Scientific Officer of Glenmark Pharmaceuticals Ltd., based in Neuchâtel, Switzerland. He oversees global research and early development of innovative products including new biological entities and new chemical entities, with operations in Switzerland, U.S. and India. He also manages both the generics and branded formulations research. Dr. Stoeckli brings more than 25 years of experience in the global life sciences industry where he focused on biopharmaceutical research and development. Prior to joining Glenmark Pharmaceuticals in 2016, Dr. Stoeckli assumed executive roles at SANOFI, first as global therapeutic area head of immunology and inflammation in Germany, and most recently as Group Vice President for the Global Biotherapeutics Division, in Paris. Dr. Stoeckli first joined industry in 1993 with Novartis in Basel, Switzerland where he held increasing leadership positions and provided global support for all biomedical research activities at the Novartis Lead Discovery Center. An immunologist and chemist by training, he graduated from the University of Basel, ETH Zurich and the Max-Planck-Institute for Neurobiology in Munich where he received his Ph.D. in Molecular Cell Biology. Dr. Stoeckli is a Postdoctoral Fellow & Assistant Professor in the Department of Biochemistry & Biophysics, University of California Medical Center.
President and Chief Medical OfficerDr. Fred Grossman
Dr. Fred Grossman, DO, FAPA is President and Chief Medical Officer of Glenmark Pharmaceuticals Ltd. He oversees global clinical development, pharmacovigilance, medical affairs and clinical operations for innovative product development, as well as specialty and generic products. In this role, he furthers Glenmark’s investments in research to generate assets that address unmet medical needs in a variety of therapeutic areas. Dr. Grossman has more than 20 years of international experience directing research and development for potential new medicines for leading pharmaceutical organizations. Before joining Glenmark in 2015, he held global medical leadership positions at Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb, and Sunovion. Dr. Grossman is a board-certified physician, completed a fellowship in pharmacology at the National Institutes of Health, has several academic appointments and is the author of numerous scientific publications. He received his medical degree from Hahnemann University in Philadelphia, Pennsylvania.
President and the Global Chief Finance OfficerMr. P. Ganesh
Mr. P. Ganesh is President and Global Chief Finance Officer of Glenmark Pharmaceuticals Ltd. He is responsible for the company’s worldwide finance operations, including global accounting, planning & analysis, financial reporting, tax and treasury functions. He has over two decades of industry experience in domestic and international markets. His experience spans across accounts, business finance, mergers & acquisitions, investor relations and banking. Prior to joining Glenmark in 2016, he was the Chief Finance Officer and Company Secretary at Godrej Industries Ltd. He has also been conferred with the ‘Best CFO’ award by Business Today, one of India’s leading business magazines, in the years 2010 and 2013, during his stint with Godrej Consumer Products Ltd. He is a qualified Chartered Accountant, Cost & Management Accountant and Company Secretary.
President, North America and Global API BusinessMr. Robert Matsuk
Mr. Robert Matsuk is President of North America at Glenmark Pharmaceuticals Ltd. He has overall responsibility for the company’s generics and branded pharmaceutical business across North America as well as the global API business at Glenmark. Prior to joining Glenmark in 2014, he was Executive Vice President and Chief Strategy Officer at HighPoint Solutions where he had overall responsibility for the Life Sciences business. Mr. Matsuk also held other senior leadership positions within the Life Sciences industry at PricewaterhouseCoopers and Computer Sciences Corporation. He received his Masters in Business Administration from Northwestern University’s J.L. Kellogg Graduate School of Management and graduated from the Philadelphia College of Pharmacy and Science with a Bachelor’s of Pharmacy degree.
President, India Formulations & MEA (Middle East & Africa) RegionMr. Sujesh Vasudevan
Mr. Sujesh Vasudevan is Glenmark’s President, India Formulations and the Middle East & Africa (MEA) regions. He has overall responsibility of the company’s generics and branded pharmaceutical businesses across India, Middle East and Africa. Prior to joining Glenmark in 2013, he served as Director of Sales & Marketing at Abbott India Limited. Mr. Vasudevan has completed the Advanced Management Program from Harvard Business School. He has also received a Master's degree in Management Studies from K J Somaiya Institute of Management Studies & Research and holds a Bachelor’s degree in Pharmacy from KM Kundnani College of Pharmacy, Mumbai.
President, Global Innovative Product Development GroupMr. Robert Jackson
Mr. Robert Jackson is President, Global Innovative Product Development Group at Glenmark Pharmaceuticals Ltd. He leads global product development in the innovative and specialty portfolio at Glenmark. Prior to joining Glenmark in 2015, Mr. Jackson amassed more than 30 years of experience in pharmaceutical research and development including leadership roles in global manufacturing, regulatory affairs, technical research and development, quality assurance, quality control & corporate project management, and pre- & post-approval drug development for more than a dozen approved products in a variety of therapeutic areas at companies like Forest Laboratories, Inc. and Novartis. He received his Masters in Business Administration in Pharmaceutical Studies from Fairleigh Dickinson University, New Jersey and a Bachelor of Science in Biochemistry from Lynchburg College, Virginia.
President and the Global Head of OperationsMr. Kanish Malik
Mr. Kanish Malik is President and the Global Head of Operations at Glenmark Pharmaceuticals Ltd. In his role, he oversees the operations of 17 manufacturing facilities spread across 4 continents that produce branded & generic medicines as well as active pharmaceutical ingredients. He also manages the global supply chain for the organization. Mr. Malik has over 25 years of industry experience in operations, supply chain management and leading large sophisticated manufacturing & service-oriented organizations. Prior to joining Glenmark in 2015, Mr. Malik previously worked with PepsiCo & Unilever and has held a wide range of roles in India & throughout the Asia Pacific Region. He holds a bachelor's degree in Chemical Engineering from Punjab University, India.
President, Global QualityDr. Darshan Makhey
Dr. Darshan Makhey is President, Global Quality at Glenmark Pharmaceuticals Ltd. In this role he has the critical responsibility of protecting and enhancing Glenmark’s reputation for high-quality and reliable products across a variety of disease states. Dr. Makhey has over 20 years of experience in the industry. He has served in a variety of strategic leadership and executive roles, with increasing responsibility across multiple organizations including quality and compliance. Prior to joining Glenmark in 2012, he was Head of Global Quality at Dr. Reddy's Laboratories Ltd. He received a PhD in Medicinal Chemistry from Rutgers, The State University of New Jersey.